文献速递主动脉疾病

移植物Nellix装置失败机制分析

Nellix Device Failure Mechanisms Analysis on Explanted Grafts.
PubMed 文献 · J Endovasc Ther · 2024-08-27

为理解Nellix腔内动脉瘤封堵装置耐久性差的原因,对21例因内漏和移位取出的Nellix内移植物进行视觉检查,并对其中4个装置的聚合物囊袋进行体外植入复制实验。结果显示医源性缺陷影响16个(76%)金属支架和20个(95%)囊袋,15例(71%)聚合物因降解而崩解;聚合物脱水时可失去超过70%的初始重量,置于盐水中可恢复80%。作者认为聚合物结构降解可能导致内漏和/或装置移位。

要点

  • 医源性缺陷影响16个(76%)金属支架和20个(95%)囊袋。
  • 15例(71%)聚合物因降解而崩解。
  • 聚合物脱水时可失去超过70%的初始重量,置于盐水中可恢复80%。

核心结论

  • 聚合物脱水时可失去重量和体积,这种结构降解可能导致内漏和/或装置移位。

研究设计与样本

  • 对21例因内漏和移位取出的Nellix内移植物进行视觉检查,并对其中4个装置的聚合物囊袋进行仪器检查。
  • 从每个装置中取2.0克聚合物切片,在包含湿相和干相的体外植入复制中测试。
  • 湿相中将样品置于含生理盐水的烧杯中,模拟植入时囊袋充盈;干相中暴露于37°C、60%湿度环境,模拟动脉瘤囊内植入后条件。

主要发现

  • 医源性缺陷影响16个(76%)金属支架和20个(95%)囊袋。
  • 15例(71%)聚合物因降解而崩解。
  • 聚合物部分脱水时可失去超过70%的初始重量,置于盐水中可恢复80%。
  • 研究阶段观察到体积减小和聚合物碎裂。

临床怎么用

  • 基于既往研究结果,因可能的血管内装置降解,应终身监测携带内移植物的患者,Nellix装置也不例外。
  • 尽管Nellix已撤市,仍有大量患者携带此类内移植物;因其中期和长期性能不可预测,应建议这些患者每6个月加强终身监测。
  • 随访中任何可疑情况必须认真对待,并应考虑取出装置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To understand possible reasons for poor durability of the Nellix (Endologix Inc., Irvine, USA) endovascular aneurysm sealing (EVAS) device. MATERIALS AND METHODS: 21 Nellix endoprostheses explanted for endoleaks and migration underwent visual examinations of stent structures and instrumental examinations of the polymer endobags on 4 devices. We harvested 2.0-gram polymer slices out of each of them and tested the samples in an in vitro implantation replication that included wet and dry exposures. During the wet phase, we placed samples in a beaker with saline, mimicking the filling of the endobags during implantation. An exposure to a 37°C environment with 60% humidity during the dry phase replicated the postimplantation conditions inside the aneurysmal sac. RESULTS: Iatrogenic defects affected 16 (76%) metal stents and 20 (95%) endobags. The polymer was disintegrated owing to degradation in 15 (71%) cases. The polymer could lose more than 70% of its initial weight when partially dehydrated and regain 80% when placed in saline. We observed volume decrease and polymer fragmentation during these study phases. CONCLUSIONS: The polymer can lose weight and volume while it dehydrates. This structural degradation of the polymer could lead to the development of endoleaks and/or migration of the device.Clinical ImpactBased on the results of previous investigations, due to possible endovascular device degradation, patients with endografts should be offered life-long surveillance, and the Nellix device is no exception. Herein we suggest polymer degradation as one of the possible reasons for the device failure. Although Nellix has been withdrawn from the market, there are numerous patients with this type of endograft. Due to its unpredictable performance in the medium and long term, these patients should be recommended enhanced life-long surveillance every 6 months. Any suspicious conditions during the follow-up must be taken seriously and explantation should be considered.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Christ L, Kuntz S, Vakhitov D, et al. Nellix Device Failure Mechanisms Analysis on Explanted Grafts. J Endovasc Ther. 2024. PMID: 39188181. doi:10.1177/15266028241274736

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。